EIM
Essex Investment Management Portfolio holdings
AUM
$550M
1-Year Return
61.92%
This Quarter Return
+12.91%
1 Year Return
+61.92%
3 Year Return
+215.25%
5 Year Return
+515.98%
10 Year Return
+2,449.6%
AUM
$507M
AUM Growth
-$1.25M
(-0.25%)
Cap. Flow
-$47.3M
Cap. Flow
% of AUM
-9.33%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
339
New
24
Increased
78
Reduced
100
Closed
33
Top Buys
| 1 |
Tower Semiconductor
TSEM
|
+$5.52M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$4.54M |
| 3 |
Dynavax Technologies
DVAX
|
+$3.46M |
| 4 |
NextEra Energy, Inc.
NEE
|
+$2.57M |
| 5 |
OneSpan
OSPN
|
+$2.55M |
Top Sells
| 1 |
Sterling Infrastructure
STRL
|
+$10.7M |
| 2 |
HCI Group
HCI
|
+$5.53M |
| 3 |
Endava
DAVA
|
+$4.61M |
| 4 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$3.95M |
| 5 |
Kornit Digital
KRNT
|
+$3.52M |
Sector Composition
| 1 | Industrials | 27.31% |
| 2 | Technology | 26.26% |
| 3 | Healthcare | 17.88% |
| 4 | Financials | 6.02% |
| 5 | Consumer Discretionary | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Avient
AVNT
$3.33B
| $1.51M | 0.3% |
34,740
-7,283
| -17% | -$316K |
|
127
Lantronix
LTRX
$175M
| $1.44M | 0.28% |
404,158
+6,171
| +2% | +$22K |
|
128
Phreesia
PHR
$1.46B
| $1.43M | 0.28% |
59,764
+1,102
| +2% | +$26.4K |
|
129
Air Products & Chemicals
APD
$65.6B
| $1.41M | 0.28% |
5,819
-283
| -5% | -$68.6K |
|
130
MYR Group
MYRG
$2.77B
| $1.36M | 0.27% |
+7,686
| New | +$1.36M |
|
131
MP Materials
MP
$11.2B
| $1.35M | 0.27% |
94,417
-20,035
| -18% | -$287K |
|
132
Caesarstone
CSTE
$50.1M
| $1.35M | 0.27% |
329,827
+155,956
| +90% | +$638K |
|
133
Biodesix
BDSX
$54M
| $1.32M | 0.26% |
925,614
+12,669
| +1% | +$18.1K |
|
134
DLH Holdings
DLHC
$79.6M
| $1.31M | 0.26% |
98,622
+1,364
| +1% | +$18.1K |
|
135
Colgate-Palmolive
CL
$67.7B
| $1.3M | 0.26% |
14,410
| – | – |
|
136
SOPHiA GENETICS
SOPH
$210M
| $1.3M | 0.26% |
262,834
+138,933
| +112% | +$685K |
|
137
Arthur J. Gallagher & Co
AJG
$76.6B
| $1.23M | 0.24% |
4,902
| – | – |
|
138
LiveRamp
RAMP
$1.73B
| $1.18M | 0.23% |
34,221
+169
| +0.5% | +$5.83K |
|
139
Symbotic
SYM
$5.32B
| $1.1M | 0.22% |
24,516
+2,490
| +11% | +$112K |
|
140
Frontdoor
FTDR
$4.86B
| $1.1M | 0.22% |
33,791
+174
| +0.5% | +$5.67K |
|
|
RVNC
141
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.08M | 0.21% |
220,160
+97,741
| +80% | +$481K |
|
142
OptimizeRx
OPRX
$343M
| $1.05M | 0.21% |
+86,656
| New | +$1.05M |
|
143
inTEST
INTT
$89.8M
| $979K | 0.19% |
73,878
| – | – |
|
144
Hudson Technologies
HDSN
$442M
| $975K | 0.19% |
88,545
| – | – |
|
145
Constellation Brands
STZ
$24.6B
| $973K | 0.19% |
3,582
-2,422
| -40% | -$658K |
|
146
Marsh & McLennan
MMC
$100B
| $972K | 0.19% |
4,719
-392
| -8% | -$80.7K |
|
147
Adaptive Biotechnologies
ADPT
$1.96B
| $889K | 0.18% |
277,096
+5,183
| +2% | +$16.6K |
|
148
Nova
NVMI
$8.74B
| $855K | 0.17% |
4,822
| – | – |
|
149
Geospace Technologies
GEOS
$210M
| $831K | 0.16% |
62,997
| – | – |
|
150
JPMorgan Chase
JPM
$844B
| $784K | 0.15% |
3,912
-265
| -6% | -$53.1K |
|